A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13. (2018)
Attributed to:
Development and testing of novel recombinant pnemococcal glyconjugate vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41541-018-0090-4
PubMed Identifier: 30393571
Publication URI: http://europepmc.org/abstract/MED/30393571
Type: Journal Article/Review
Volume: 3
Parent Publication: NPJ vaccines
ISSN: 2059-0105